Getwell Pharma India Private Limited — Cyclophosphamide Exporter Profile
Indian Pharmaceutical Exporter · #11 for Cyclophosphamide · $139.9K export value · DGFT Verified
Getwell Pharma India Private Limited is the #11 Indian exporter of Cyclophosphamide with $139.9K in export value and 71 verified shipments. Getwell Pharma India Private Limited holds a 0.7% market share in Cyclophosphamide exports across 13 countries. The company exports 10 pharmaceutical products worth $4.6M across 3 therapeutic categories.
Getwell Pharma India Private Limited — Cyclophosphamide Export Profile: Buyers & Destinations
Where Does Getwell Pharma India Private Limited Export Cyclophosphamide?
| Country | Value | Shipments | Share |
|---|---|---|---|
| PHILIPPINES | $277.3K | 56 | 72.6% |
| SRI LANKA | $34.0K | 11 | 8.9% |
| JAMAICA | $18.5K | 25 | 4.8% |
| MAURITIUS | $11.7K | 14 | 3.1% |
| NEPAL | $10.3K | 18 | 2.7% |
| KENYA | $6.6K | 20 | 1.7% |
| TRINIDAD & TOBAGO | $5.3K | 2 | 1.4% |
| MADAGASCAR | $4.7K | 4 | 1.2% |
| TRINIDAD AND TOBAGO | $3.5K | 3 | 0.9% |
| GEORGIA | $2.6K | 1 | 0.7% |
Getwell Pharma India Private Limited exports Cyclophosphamide to 17 countries. The largest destination is PHILIPPINES accounting for 72.6% of Getwell Pharma India Private Limited's Cyclophosphamide shipments, followed by SRI LANKA (8.9%) and JAMAICA (4.8%). These destinations reflect Getwell Pharma India Private Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Cyclophosphamide from Getwell Pharma India Private Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| AMBICA INTERNATIONAL CORPORATION | PHILIPPINES | $269.0K | 55 |
| THE ESSES PHARMACY (PRIVATE) LIMITE | SRI LANKA | $25.5K | 7 |
| RECHARGED DISTRIBUTORS LIMITED | JAMAICA | $18.5K | 25 |
| THE MAURITIUS PHARMACY (SEEGOBIN) L | MAURITIUS | $10.6K | 3 |
| SUNCREST INTERNATIONAL LIMITED | TRINIDAD AND TOBAGO | $8.8K | 3 |
| AMBICA INTERNATIONAL CORPORATI | PHILIPPINES | $8.3K | 1 |
| THE ESSES PHARMACY(PRIVATE) LIMITED | SRI LANKA | $7.4K | 3 |
| VISION CARE INTERNATIONAL PVT. LTD. | NEPAL | $7.2K | 13 |
| CENTRALE D'ACHATS DE MEDICAMENTS | MADAGASCAR | $4.7K | 3 |
| TSOMBO LLC | MONGOLIA | $4.0K | 6 |
Getwell Pharma India Private Limited supplies Cyclophosphamide to 28 buyers globally. The largest buyer is AMBICA INTERNATIONAL CORPORATION (PHILIPPINES), followed by THE ESSES PHARMACY (PRIVATE) LIMITE (SRI LANKA) and RECHARGED DISTRIBUTORS LIMITED (JAMAICA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Cyclophosphamide Export Value and How Much Does Getwell Pharma India Private Limited Contribute?
India exported $4.6M worth of Cyclophosphamide through 2,113 shipments from 259 suppliers to 114 countries, serving 518 buyers globally. Getwell Pharma India Private Limited contributes $139.9K to this total, accounting for 0.7% of India's Cyclophosphamide exports. Getwell Pharma India Private Limited ships Cyclophosphamide to 17 countries through 28 buyers.
What Is the Average Shipment Value for Getwell Pharma India Private Limited's Cyclophosphamide Exports?
Getwell Pharma India Private Limited's average Cyclophosphamide shipment value is $2.0K per consignment, based on 71 shipments totaling $139.9K. The largest destination is PHILIPPINES (72.6% of Getwell Pharma India Private Limited's Cyclophosphamide exports).
How Does Getwell Pharma India Private Limited Compare to Other Indian Cyclophosphamide Exporters?
Getwell Pharma India Private Limited ranks #11 among 259 Indian Cyclophosphamide exporters with a 0.7% market share. The top 3 exporters are EUGIA PHARMA SPECIALITIES LIMITED ($1.1M), ALEMBIC PHARMACEUTICALS LIMITED ($850.4K), CIPLA LIMITED ($550.0K). Getwell Pharma India Private Limited processed 71 shipments to 13 destination countries.
What Cyclophosphamide Formulations Does Getwell Pharma India Private Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| CYTOACE- 500 MG CYCLOPHOSPHAMIDE FOR IN | $19.3K | 4 |
| CYPHOS 200MG (CYCLOPHOSPHAMIDE FOR INJECTION USP) BATCH NO 3GCY48 MFG DT 11/2023 EXP DT 10/2025 SR NO 01200303 | $12.6K | 1 |
| GLOTOXAN 500MG (CYCLOPHOSPHAMIDE FOR INJ | $10.0K | 2 |
| GLOTOXAN-500MG (CYCLOPHOSPHAMIDE FOR INJ | $9.9K | 2 |
| GLOTOXAN-500MG CYCLOPHOSPHAMIDE FOR INJ | $9.7K | 2 |
| CYCLIXINE- 500 MG (CYCLOPHOSPHAMIDE FOR | $9.7K | 2 |
| GLOTOXAN 500MG CYCLOPHOSPHAMIDE FOR INJECTION USP BATCH NO 3GCY03 MFG DT 01 2023 EXP DT 12 2024 | $8.9K | 1 |
| GLOTOXAN 500MG CYCLOPHOSPHAMIDE FOR INJECTION USP BATCH NO 5GCY17 MFG DT 04 2025 EXP DT 03 2027 | $8.8K | 1 |
| CYTOACE- 1 G CYCLOPHOSPHAMIDE FOR INJEC | $8.7K | 1 |
| GLOTOXAN-500MG (CYCLOPHOSPHAMIDE FOR INJECTION USP)BATCH NO.4GCY11, MFG.DT. 03/2024,EXP.DT 02/2026 | $8.6K | 1 |
Getwell Pharma India Private Limited exports 111 distinct Cyclophosphamide formulations including tablets, capsules, syrups, and combination drugs. The top formulation is CYTOACE- 500 MG CYCLOPHOSPHAMIDE FOR IN with 4 shipments worth $19.3K.
How Does Getwell Pharma India Private Limited Compare to Nearest Cyclophosphamide Exporters?
Exporters ranked immediately above and below #11 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 9 | 3S CORPORATION | $171.1K | 35 | 5 | $4.9K |
| 10 | VIVALIA REMEDIES PRIVATE LIMITED | $147.8K | 4 | 1 | $37.0K |
| 11 | GETWELL PHARMA INDIA PRIVATE LIMITED ★ | $139.9K | 71 | 13 | $2.0K |
| 12 | GLS PHARMA LIMITED | $120.3K | 32 | 5 | $3.8K |
| 13 | UNITED BIOTECH PRIVATE LIMITED | $110.4K | 75 | 9 | $1.5K |
Getwell Pharma India Private Limited ranks #11 among 259 Indian Cyclophosphamide exporters. Average shipment value of $2.0K compared to the market average of $17.9K. The closest competitors by value are 3S CORPORATION and VIVALIA REMEDIES PRIVATE LIMITED.
Which Indian Ports Ship Cyclophosphamide Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 561 | 26.5% |
| SAHAR AIR CARGO ACC (INBOM4) | 442 | 20.9% |
| DELHI AIR | 246 | 11.6% |
| DELHI AIR CARGO ACC (INDEL4) | 189 | 8.9% |
| Bombay Air | 154 | 7.3% |
| Delhi Air | 51 | 2.4% |
| Bombay Air Cargo | 51 | 2.4% |
| HYDERABAD AIR | 36 | 1.7% |
What Other Oncology Products Does Getwell Pharma India Private Limited Export?
Getwell Pharma India Private Limited also exports these oncology products. Each links to the detailed product page.
About Getwell Pharma India Private Limited
Getwell Pharma India Private Limited exports 10 products worth $4.6M. Beyond Cyclophosphamide, top products include Paclitaxel, Protein, Doxorubicin, Gemcitabine, Fluorouracil. View the complete Getwell Pharma India Private Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Cyclophosphamide — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Cyclophosphamide shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Getwell Pharma India Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 165 individual customs records matching Getwell Pharma India Private Limited exporting Cyclophosphamide, covering 111 formulations to 17 countries via 28 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 114+ countries, 518+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Cyclophosphamide Export Data from Getwell Pharma India Private Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Getwell Pharma India Private Limited's Cyclophosphamide exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Getwell Pharma India Private Limited
Full Company Profile →
10 products · $4.6M total trade · 3 categories
Cyclophosphamide Stats
Company Overview
Top Products by Getwell Pharma India Private Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Getwell Pharma India Private Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Cyclophosphamide. For current shipment-level data, contact TransData Nexus.